EUCTR2009-014997-16-AT进行中（未招募）1 期
Identification of patients with high probability of not or poorly responding to therapy with mycophenolic acid pro-drugs.
Medizinische Universität Wien, Abteilung für Nephrologie und Dialyse0 个研究点目标入组 150 人开始时间: 2009年10月21日最近更新:
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 150
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •de novo kidney graft
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •highly immunized patients (due to previous transplantations etc) with PRA levels >40%
研究者
相似试验
已完成
2 期
Early identification of patients who benefit from palbociclib in addition to letrozole10027476Metastatic breast cancerNL-OMON46198niversitair Medisch Centrum Groningen30
进行中（未招募）
1 期
Early identification of patients who benefit from palbociclib in addition to letrozoleEUCTR2015-004231-12-NLniversity Medical Center Groningen
已完成
不适用
TOPSbreast cancerJPRN-UMIN000037067Osaka International Cancer Institute200
Unknown
不适用
Decision tool topklinische GGZ voor ouderen met een persoonlijkheidsstoornis: Ontwikkeling en validering.Personality disorder, older adultsNL-OMON20506Mondriaan Hospital, Department of Old Age Psychiatry.90
已完成
不适用
Study on the selection of appropriate patients for the dose escalation of adalimumab in Crohn's disease therapy.Crohn'diseaseJPRN-UMIN000024566Toho University Medical Center Sakura Hospital60